ImmunityBio (IBRX) outlook covering core growth engines, ANKTIVA revenue, pipeline risks, bull vs bear case, and long-term investor value.

seen from Italy
seen from United States
seen from Malaysia
seen from China

seen from United States

seen from Germany

seen from United States

seen from Germany
seen from United States
seen from United States

seen from United States

seen from Malaysia
seen from United States
seen from Russia
seen from China

seen from United States
seen from United States
seen from United States
seen from Qatar
seen from United States
ImmunityBio (IBRX) outlook covering core growth engines, ANKTIVA revenue, pipeline risks, bull vs bear case, and long-term investor value.

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Unusual Trends in IBRX Behavior Detected During Financial Period Closure on Dec 31, 2023 https://csimarket.com/stocks/news.php?code=IBRX&date=2024-03-19224727&utm_source=dlvr.it&utm_medium=tumblr
Tuesday 6/6 Insider Buying Report: IBRX, FSCO
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Monday, ImmunityBio's Director, Michael D. Blaszyk, made a $198,023 buy of IBRX, purchasing 71,915 shares at a cost of $2.75 a piece. ImmunityBio is trading up about 5.7% on the day Tuesday. And at FS Credit Opportunities, there was insider buying on Thursday, by David J. Adelman who bought 40,000 shares at a cost of $4.55 each, for a total investment of $182,000. Before this latest buy, Adelman bought FSCO at 3 other times during the past year, for a total cost of $692,343 at an average of $4.52 per share. FS Credit Opportunities is trading up about 0.2% on the day Tuesday. Adelman was up about 3.1% on the buy at the high point of today's trading session, with FSCO trading as high as $4.69 in trading on Tuesday.
VIDEO: Tuesday 6/6 Insider Buying Report: IBRX, FSCO The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Source link Read the full article